July 11, 2020 - 8:00 am
July 11, 2020 - 11:30 am
The European College of Neuropsychopharmacology (ECNP) is committed to ensuring that advances in the understanding of brain function and behaviour are translated into better treatments for brain disorders and enhanced public health.
To achieve these goals, ECNP supports innovative research in neuroscience applied disciplines and facilitate the communication of ideas, discoveries and best practices. In addition, they promote the entry of early career scientists into the field and support their ongoing professional development, provide guidance and information to the public, and facilitate dialogue with regulators, government bodies, international agencies and industry.
In this symposium, four leading experts in neuroscience applied research will outline their research and the field that ECNP is representing and highlight examples how basic neuroscience findings could be translated to clinical application.
Elisabeth Binder, Max Planck Institute of Psychiatry, ECNP Vice President
“Embedding of early adversity – implications for risk trajectories in psychiatry”
John F. Cryan – APC Microbiome University College Cork, Ireland
“Brain-Body Mechanisms in Psychiatry: Translational Hurdles”
Martien Kas – Groningen Institute for Evolutionary Life Sciences, University of Groningen, the Netherlands. ECNP President Elect
“Linking neuropsychiatry to quantitative biology”
Andreas Meyer-Lindenberg – Central Institute of Mental Health, Mannhein
University of Heidelberg
“Precision prevention through characterizing neural mechanisms of environmental risk”
For further information and registration, please visit event website.